Skip to main content

Arbour Paola M's Form 4 filing

Tenet Healthcare Corp (THC) · filed Jun 6, 2023

Accession no.
0001209191-23-034775
Filed
Jun 6, 2023
Trade date
Jun 2, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.90M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Arbour Paola MCIK 0001769862Officer (EVP, Chief Information Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2023Common StockMOption exerciseAcquired+17,205$35.43+$609,573.1550,211Direct
Jun 2, 2023Common StockSSaleDisposed−17,205$75.44F2−$1,297,945.233,006Direct
Jun 2, 2023Common StockMOption exerciseAcquired+21,351$28.26+$603,379.2654,357Direct
Jun 2, 2023Common StockSSaleDisposed−21,351$75.05F3−$1,602,392.5533,006Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2023Common StockMOption exerciseDisposed−17,205$35.43−$609,573.150Direct
Jun 2, 2023Common StockMOption exerciseDisposed−21,351$28.26−$603,379.260Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $75.39 to $75.48. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $74.98 to $75.26. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)